SRSF9 and cardiac hypertrophy: To investigate whether overexpression of SRSF9 results in the same phenotype as pressure overload‐induced cardiac hypertrophy, a gain‐of‐function approach was employed by infecting with AAV9‐SRSF9 and its negative control AAV9‐Null.